Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Osteoporosis is a condition in which the amount of bone is reduced, the bones are weak, and
there is an increased risk for fractures. Glucocorticoids (such as prednisone) are prescribed
to treat a large number of conditions such as arthritis and asthma. When taken for several
months or longer, glucocorticoids can cause bone loss and lead to a form of osteoporosis
called "glucocorticoid-induced osteoporosis." This study compared the effects of
teriparatide, the study drug, with alendronate, an approved drug for treating
glucocorticoid-induced osteoporosis.